European Association for the study of diabetes

No abstract is available for this paper.

• Publication year

  1969

• Venue

  Diabetologia

• Publication date

  1969-08-01

• Fields of study

  Biology

• Identifiers
  DOI 10.1007/BF01212098
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Global challenges in diabetes research and care: which way forward? An appraisal from the EASD Global Council

  2025cites this paper
• Soluble CD163 is a predictor of fibrosis and hepatocellular carcinoma development in nonalcoholic steatohepatitis

  2023cites this paper
• Alignment of Physician-Stated vs Clinically Derived Reference Fibrosis Score in Patients with Non-Alcoholic Steatohepatitis: A Real-World European Survey

  2023cites this paper
• Serum Level of Cytokeratin 18 (M65) as a Prognostic Marker of High Cardiovascular Disease Risk in Individuals with Non-Alcoholic Fatty Liver Disease

  2023cites this paper
• Treatment responses and outcomes in patients with autoimmune hepatitis and concomitant features of non-alcoholic fatty liver disease

  2023cites this paper
• Association between the lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes in a healthy population of Northwest China: a retrospective cohort study with a 2-year follow-up period

  2023cites this paper
• Combined therapy with pioglitazone and FGF21 mRNA synergistically ameliorates metabolic disorders in NAFLD rats

  2023cites this paper
• The Multifaceted Roles of Macrophages in NAFLD Pathogenesis

  2023cites this paper
• Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Saudi Arabia: Systematic Review and Meta-analysis

  2023cites this paper
• Non-pharmacological management options for MAFLD: a practical guide

  2023cites this paper
• Fatty liver index relationship with biomarkers and lifestyle: result from RaNCD cohort study

  2023cites this paper
• The bidirectional impacts of alcohol consumption and MAFLD for progressive fatty liver disease

  2023cites this paper
• Quantitative liver health imaging improves clinical outcomes in colorectal liver metastasis surgery.

  2023cites this paper
• Developing the UVA/Padova Type 1 Diabetes Simulator: Modeling, Validation, Refinements, and Utility

  2023cites this paper
• Inhibition of Dipeptidyl Peptidase-4 Activates Autophagy to Promote Survival of Breast Cancer Cells via the mTOR/HIF-1α Pathway

  2023cites this paper
• Birth outcomes, puberty onset, and obesity as long-term predictors of biological aging in young adulthood

  2023cites this paper
• Quantitative MRI in cardiometabolic disease: From conventional cardiac and liver tissue mapping techniques to multi-parametric approaches

  2023cites this paper
• Relationship between Uric Acid to High Density Lipoprotein Cholesterol Ratio and Nonalcoholic Fatty Liver Disease in Nonoverweight/Obese Patients with Type 2 Diabetes

  2023cites this paper
• Liver fibrosis is closely related to metabolic factors in metabolic associated fatty liver disease with hepatitis B virus infection

  2023cites this paper
• Lycium barbarum Oligosaccharides Alleviate Hepatic Steatosis by Modulating Gut Microbiota in C57BL/6J Mice Fed a High-Fat Diet

  2023cites this paper
• Autoimmunity associates with severity of illness in elderly patients with drug-induced liver injury

  2023cites this paper
• Gut microbiota modulation in patients with non-alcoholic fatty liver disease: Effects of current treatments and future strategies

  2023cites this paper
• Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial

  2023cites this paper
• Prevalence and impact of non-alcoholic fatty liver disease in patients with papillary thyroid carcinoma

  2023cites this paper
• Screening for At-Risk Nonalcoholic Fatty Liver Disease in the Primary Care Setting

  2023cites this paper
• High Visceral-To-Subcutaneous Fat Ratio Is Associated with an Increased Risk of Gastroesophageal Reflux Disease in Nonobese Adults

  2023cites this paper
• Sugar-sweetened beverages, low/no-calorie beverages, fruit juice and non-alcoholic fatty liver disease defined by fatty liver index: the SWEET project

  2023cites this paper
• Comments on Relationship between the High Fatty Liver Index and Risk of Fracture: Reply

  2023cites this paper
• Hepatic triglyceride content is intricately associated with numerous metabolites and biochemical pathways

  2023cites this paper
• Effect of Aerobic Exercise on Lipid Metabolism in Rats With NAFLD

  2022cites this paper
• Metabolic mechanisms for and treatment of NAFLD or NASH occurring after liver transplantation

  2022cites this paper
• Does aerobic exercise reduce NASH and liver fibrosis in patients with non-alcoholic fatty liver disease? A systematic literature review and meta-analysis

  2022cites this paper
• Factores asociados a esteatosis hepática no alcohólica en pacientes del área rural del cantón Chambo

  2022cites this paper
• Association of NAFLD with cardiovascular disease and all-cause mortality: a large-scale prospective cohort study based on UK Biobank

  2022cites this paper
• Nonalcoholic fatty liver disease in relation to the remission and progression along the glycemic continuum

  2022cites this paper
• Metformin and Dementia Risk: A Systematic Review with Respect to Time Related Biases

  2022cites this paper
• The effects of liraglutide on liver enzymes and metabolic factors in patients with nonalcoholic steatohepatitis: a meta-analysis of randomized controlled trials

  2022cites this paper
• Incidental finding of non-alcoholic steatohepatitis-cirrhosis

  2022cites this paper
• Lrg1 inhibits the activation of hepatic macrophages to alleviate NAFLD by enhancing TGF-β1 signaling

  2022cites this paper
• Disglicemia y enfermedad de hígado graso no alcohólico en pacientes con adiposidad, Clínica Internacional, San Borja, 2019 – 2020

  2022cites this paper
• Liver fibrosis and retinal features in an older Mediterranean population: Results from the Salus in Apulia study

  2022cites this paper
• Systematic Review and Meta-Analysis of the Usefulness of Epicardial Fat Thickness as a Non-Invasive Marker of the Presence and Severity of Nonalcoholic Fatty Liver Disease

  2022cites this paper
• Comparison of the role of alcohol consumption and qualitative abdominal fat on NAFLD and MAFLD in males and females

  2022cites this paper
• Assessment of Noninvasive Markers of Steatosis and Liver Fibrosis in Human Immunodeficiency Virus-Monoinfected Patients on Stable Antiretroviral Regimens

  2022cites this paper
• A Novel Dual Incretin Agent, Tirzepatide (LY3298176), for the Treatment of Type 2 Diabetes Mellitus and Cardiometabolic Health

  2022cites this paper
• Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease

  2022cites this paper
• Emerging pharmacological treatment options for MAFLD

  2022cites this paper
• Estimating global prevalence, incidence, and outcomes of non-alcoholic fatty liver disease from 2000 to 2021: systematic review and meta-analysis

  2022cites this paper
• General Overview About the Current Management of Nonalcoholic Fatty Liver Disease

  2022cites this paper
• Combination of tofogliflozin and pioglitazone for NAFLD: Extension to the ToPiND randomized controlled trial

  2022cites this paper
• Drug-induced severe liver injury due to Sterculia versicolor: a case report with causality assessment from possible to probable

  2022cites this paper
• High Meat Consumption Is Prospectively Associated with the Risk of Non-Alcoholic Fatty Liver Disease and Presumed Significant Fibrosis

  2022cites this paper
• Mediators of dietary diversity score (DDS) on NAFLD in Iranian adults: a structural equation modeling study

  2022cites this paper
• Radiofrequency coil design for improving human liver fat quantification in a portable single‐side magnetic resonance system

  2022cites this paper
• Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Current Progresses and Challenges

  2022cites this paper
• The impact of health status, diet and lifestyle on non‐alcoholic fatty liver disease: Narrative review

  2022cites this paper
• Clinical presentation and long‐term outcome of patients with KCNJ11/ABCC8 variants: Neonatal diabetes or MODY in the DPV registry from Germany and Austria

  2022cites this paper
• Which is the optimal antiobesity agent for patients with nonalcoholic fatty liver disease?

  2022cites this paper
• Risk Factor Evaluation of Non Alcoholic Fatty Liver Disease in Lean Individual

  2022cites this paper
• Blood and urine manganese exposure in non-alcoholic fatty liver disease and advanced liver fibrosis: an observational study

  2022cites this paper
• Nonalcoholic Fatty Liver Disease before Kidney Transplantation Correlates with New Onset Diabetes and Poor Metabolic Outcomes

  2022cites this paper
• Role of non-invasive methods in detecting liver impairment in familial Mediterranean fever adult patients with persistent hepatic cytolysis

  2022cites this paper
• Risk of liver‐related events by age and diabetes duration in patients with diabetes and nonalcoholic fatty liver disease

  2022cites this paper
• Long-chain saturated fatty acids and its interaction with insulin resistance and the risk of nonalcoholic fatty liver disease in type 2 diabetes in Chinese

  2022cites this paper
• Busting the myth of methotrexate chronic hepatotoxicity

  2022cites this paper
• Nonalcoholic Fatty Liver Disease: An Emerging Modern-Day Risk Factor for Cardiovascular Disease

  2022cites this paper
• Cardiovascular disease risk in paediatric and young adult non-alcoholic fatty liver disease

  2022cites this paper
• GEORGIAN MEDICAL NEWS No 1 ( 322 ) 2022

  2022cites this paper
• Development of Food Group Tree-Based Analysis and Its Association with Non-Alcoholic Fatty Liver Disease (NAFLD) and Co-Morbidities in a South Indian Population: A Large Case-Control Study

  2022cites this paper
• Clinical applications of circulating tumor cells in hepatocellular carcinoma

  2022cites this paper
• Five regions, five retinopathy screening programmes: a systematic review of how Portugal addresses the challenge

  2021cites this paper
• Prevalence of Metabolic Syndrome and Associated Factors in Type 2 Diabetes Mellitus: A Descriptive Cross-Sectional Study at a Follow-up Clinic in Asmara, Eritrea

  2021cites this paper
• Expert Opinion on the Management of Non-Alcoholic Fatty Liver Disease (NAFLD) in the Middle East with a Focus on the Use of Silymarin

  2021cites this paper
• Validation of a Novel Cutoff Point for the Fibrosis-4 Index Modified by Age in Patients with Fatty Liver Diseases

  2021cites this paper
• Macrophages as a source of fibrosis biomarkers for non-alcoholic fatty liver disease

  2021cites this paper
• Maggot debridement therapy for the treatment of diabetic foot ulcers: robbing the rich past to give to the sore

  2021cites this paper
• In vitro study of the drug–drug interaction potential of cetagliptin and clinical study of pharmacokinetic interaction of cetagliptin and metformin in healthy volunteers

  2021cites this paper
• Metformin-loaded lecithin nanoparticles induce colorectal cancer cytotoxicity via epigenetic modulation of noncoding RNAs

  2021cites this paper
• Percutaneous mechanical thrombectomy device assisted TIPS recanalization: a feasibility study

  2021cites this paper
• A cross-sectional study of the correlation between diabetic therapy and serum zinc concentrations

  2021cites this paper
• The effectiveness and safety of recombinant human growth hormone combined with alginate dressing in the treatment of diabetic foot ulcer

  2021cites this paper
• Ethnopharmacological perspectives of glucokinase activators in the treatment of diabetes mellitus

  2021cites this paper
• The Women’s Leadership Gap in Diabetes: A Call for Equity and Excellence

  2021cites this paper
• Association between the liver fat score (LFS) and cardiovascular diseases in the national health and nutrition examination survey 1999–2016

  2021cites this paper
• Obesity and metabolic syndrome induce hyperfiltration, glomerulomegaly, and albuminuria in obese ovariectomized female mice and obese male mice

  2021cites this paper
• Diagnostic and therapeutic decisions of general practitioners in patients with suspected or diagnosed non-alcoholic fatty liver disease with reference to current European guidelines

  2020cites this paper
• Psychometric Analysis Regarding the Barriers to Providing Effective Insulin Treatment in Type 2 Diabetic Patients

  2020cites this paper
• Nutritional Therapy for Athletes with Diabetes

  2020cites this paper
• DMSO_A_246281 1459..1464

  2020cites this paper
• Five Regions, Five Retinopathy Screening Programmes: A Systematic Review of the Portuguese Experience

  2020cites this paper
• Changes in Serum Nesfatin-1 After Laparoscopic Sleeve Gastrectomy are Associated with Improvements in Nonalcoholic Fatty Liver Disease

  2020cites this paper
• Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders

  2020cites this paper
• Frequently abnormal serum gamma-glutamyl transferase activity is associated with future development of fatty liver: a retrospective cohort study

  2020cites this paper
• Epigenetic modification and therapeutic targets of diabetes mellitus

  2020cites this paper
• The FDA Metformin Label Change and Racial and Sex Disparities in Metformin Prescription among Patients with CKD.

  2020cites this paper
• Mechanisms of metformin inhibiting cancer invasion and migration.

  2020cites this paper
• Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)

  2020cites this paper
• Effectiveness of a comprehensive care protocol in patients with new diagnoses of type 2 diabetes mellitus and associated comorbidities in primary care: study protocol of a quasi-experimental trial

  2020cites this paper
• Traditional Chinese medicine Lingguizhugan decoction treating non-alcoholic fatty liver disease with spleen-yang deficiency pattern: Study protocol for a multicenter randomized controlled trial

  2019cites this paper
• Diabetes, a Contemporary Risk for Parkinson’s Disease: Epidemiological and Cellular Evidences

  2019cites this paper